Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Depth Of ‘Complete’ Molecular Response Predicts Molecular Relapse In Chronic Myeloid Leukaemia Patients On Tyrosine Kinase Inhibitor Therapy

Heledd Thomas, BSc, Jane F Apperley, MD, Richard M Szydlo, PhD, Gareth Gerrard, PhD, David Marin, MD, Dragana Milojkovic, PhD, Letizia Foroni, MD

Blood (2013) 122 (21): 5201.

https://doi.org/10.1182/blood.V122.21.5201.5201

Published: 2013

Journal Articles

Dose Interruption/Reduction Of Tyrosine Kinase Inhibitors In The First 3 Months Of Treatment of CML Is Associated With Inferior Early Molecular Responses and Predicts For An Increased Likelihood Of Discontinuation Of The 1st Line Agent

Jane F Apperley, MD, Richard M Szydlo, PhD, Gareth Gerrard, PhD, James R McCue, Jamie Wardle, Richard E Clark, MD, Stephen G O'Brien, Letizia Foroni, MD

Blood (2013) 122 (21): 93.

https://doi.org/10.1182/blood.V122.21.93.93

Published: 2013

Journal Articles

Association between the Polycomb Group (PcG) BMI-1 Gene Expression and Outcome in Chronic Myeloid Leukemia (CML) Patients Receiving Allogeneic Stem Cell Transplantation (allo-SCT).

Mohamad Mohty, MD, PhD, Agnes S.M. Yong, MD, PhD, Richard M. Szydlo, PhD, Jane F. Apperley, MD, John M. Goldman, MD, Junia V. Melo, MD, PhD

Blood (2007) 110 (11): 464.

https://doi.org/10.1182/blood.V110.11.464.464

Published: 2007

Journal Articles

C-Reactive Protein on Admission Predicts Transplant-Related Mortality in Recipients of Allogeneic Stem Cell Transplant.

Andrea K. Kew, MD, Richard M. Szydlo, PhD, Eduardo Olavarria, MD, PhD, John M. Goldman, DM, Jane F. Apperley, MD

Blood (2007) 110 (11): 3005.

https://doi.org/10.1182/blood.V110.11.3005.3005

Published: 2007

Journal Articles

Molecular Profiling of CD34+ Cells from Diagnosis in CML Patients Identifies Low Expression of CD7 with High Expression of Proteinase 3 or Elastase as Predictors of Longer Survival.

Agnes S.M. Yong, MD, PhD, Richard M. Szydlo, PhD, John M. Goldman, MD, Jane F. Apperley, MD, Junia V. Melo, MD, PhD

Blood (2005) 106 (11): 1984.

https://doi.org/10.1182/blood.V106.11.1984.1984

Published: 2005

NARROW

The Depth Of ‘Complete’ Molecular Response Predicts Molecular Relapse In Chronic Myeloid Leukaemia Patients On Tyrosine Kinase Inhibitor Therapy

Dose Interruption/Reduction Of Tyrosine Kinase Inhibitors In The First 3 Months Of Treatment of CML Is Associated With Inferior Early Molecular Responses and Predicts For An Increased Likelihood Of Discontinuation Of The 1st Line Agent

Association between the Polycomb Group (PcG) BMI-1 Gene Expression and Outcome in Chronic Myeloid Leukemia (CML) Patients Receiving Allogeneic Stem Cell Transplantation (allo-SCT).

C-Reactive Protein on Admission Predicts Transplant-Related Mortality in Recipients of Allogeneic Stem Cell Transplant.

Molecular Profiling of CD34+ Cells from Diagnosis in CML Patients Identifies Low Expression of CD7 with High Expression of Proteinase 3 or Elastase as Predictors of Longer Survival.

Email alerts

ASH Publications

American Society of Hematology

The Depth Of ‘Complete’ Molecular Response Predicts Molecular Relapse In Chronic Myeloid Leukaemia Patients On Tyrosine Kinase Inhibitor Therapy

Dose Interruption/Reduction Of Tyrosine Kinase Inhibitors In The First 3 Months Of Treatment of CML Is Associated With Inferior Early Molecular Responses and Predicts For An Increased Likelihood Of Discontinuation Of The 1st Line Agent

Association between the Polycomb Group (PcG) BMI-1 Gene Expression and Outcome in Chronic Myeloid Leukemia (CML) Patients Receiving Allogeneic Stem Cell Transplantation (allo-SCT).

C-Reactive Protein on Admission Predicts Transplant-Related Mortality in Recipients of Allogeneic Stem Cell Transplant.

Molecular Profiling of CD34+ Cells from Diagnosis in CML Patients Identifies Low Expression of CD7 with High Expression of Proteinase 3 or Elastase as Predictors of Longer Survival.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only